Lisinopril Tablets Recalled for Stray Amlodipine Tablet Contamination
NCS Healthcare recalled Lisinopril Tablets USP 20 mg nationwide due to potential presence of stray Amlodipine Besylate 10 mg tablets in certain lots. No illnesses have been reported.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard—stray tablets of a different pharmaceutical—presents a potential medication error risk, but the classification as Class III combined with the absence of reported patient harm places this in the low-risk contamination category.
Plain-English summary
NCS Healthcare of Kentucky Inc is recalling Lisinopril Tablets USP 20 mg (15-count and 30-count blister cards) due to the potential presence of stray Amlodipine Besylate 10 mg tablets within certain lots. The affected lot is number 8255-3012 with expiration date 08/31/2024.
The recall affects customers nationwide. Patients who may have received affected product should verify they have the correct medication. Any patient or healthcare provider who believes they have received affected product should contact their pharmacy or healthcare provider.
Patients currently taking Lisinopril or Amlodipine should continue their medication as prescribed and consult their healthcare provider if they have questions about the safety or authenticity of their medication.
The recalled product
- Product
- BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
- Brand
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- NCS Healthcare of Kentucky Inc
- Category
- Drug
- Affected units
- 12
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot#: a) 8255-3012
- Exp 08/31/2024
- b) 8255-3012
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by NCS Healthcare of Kentucky Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · BUSPIRONE HYDROCHLORIDE
- LowBuspirone Hydrochloride Tablets 5 mg Recalled for Subpotency
FDA (Drugs) · 2026-05-13
- HighBuspirone Hydrochloride Tablets Recalled Due To Amlodipine Contamination Risk
FDA (Drugs) · 2023-11-29
- ModerateDrug Recall: Buspirone Tablets Over Manufacturing Process Deviations
FDA (Drugs) · 2023-05-03
- ModerateAccord Healthcare Recalls Buspirone Hydrochloride Tablets Due to Manufacturing Violations
FDA (Drugs) · 2023-03-08
- ModerateAccord Healthcare Recalls Buspirone Hydrochloride Due to Manufacturing Deviations
FDA (Drugs) · 2023-03-08
Same manufacturer · NCS Healthcare of Kentucky Inc
See all →- SevereNCS Healthcare Recalls Glycopyrrolate Tablets Due to Impurity Failure
FDA (Drugs) · 2020-02-26
Same hazard · foreign tablets
See all →- HighTrazodone tablets recalled over the presence of foreign tablets
FDA (Drugs) · 2026-02-11
- HighBaclofen tablet bottles recalled over the presence of foreign tablets
FDA (Drugs) · 2025-12-24
- ModeratePrescription statin LIVALO tablets recalled due to foreign tablets in bottles
FDA (Drugs) · 2025-03-19
- HighGabapentin 600 mg Tablets Recalled Due to Metformin Contamination
FDA (Drugs) · 2024-08-14
- ModerateEzetimibe and Simvastatin Tablets Recalled for Defective Excipient and Foreign Tablets
FDA (Drugs) · 2021-11-17
Similar recalls
- HighLupin Recalls Lisinopril Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2020-08-05
- ModerateLupin Recalls Lisinopril Tablets Due to Foreign Tablet Mix-Up
FDA (Drugs) · 2020-04-08
- HighBuspirone Hydrochloride Tablets Recalled for Foreign Tablet Contamination
FDA (Drugs) · 2021-06-09
- ModerateLupin Recalls 20 mg Lisinopril Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-04-29
- ModerateAscend Amlodipine Besylate Tablets Recalled for Foreign Tablet Presence
FDA (Drugs) · 2017-09-20
- LowLupin Recalls Lisinopril Tablets Due to CGMP Deviations
FDA (Drugs) · 2016-09-28